Pharmacokinetic factors affecting airway selectivity of inhaled steroids - role of intracellular esterification Source: Eur Respir J 2001; 18: Suppl. 33, 147s Year: 2001
Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma Source: Eur Respir J 2006; 28: 1042-1050 Year: 2006
Prolonged activity where it matters - the reversible esterfication of budesonide improves its topical anti-inflammatory efficacy and selectivity in the airways Source: Eur Respir J 2001; 18: Suppl. 33, 21s Year: 2001
Systemic bioavailability of inhaled steroids: the importance of appropriate and comparable methodology Source: Eur Respir J 2001; 17: 157-158 Year: 2001
Carrier-mediated disposal mechanisms for long-acting β2 -agonists in the airway: the emerging role of corticosteroid sensitivity Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD Year: 2008
Mechanisms of systemic side effects of inhaled steroids Source: Eur Respir J 2004; 24: Suppl. 48, 347s Year: 2004
The combination of budesonide and formoterol exerts more rapid and enhanced anti-inflammatory effects than either drug alone in rat lungs in vivo Source: Eur Respir J 2004; 24: Suppl. 48, 344s Year: 2004
Tpi 1020, a novel inhaled anti-inflammatory drug, has a different pharmacokinetic profile and lower effect on urinary free cortisol as compared to budesonide Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009
Effect of a novel inhaled glucocorticoid, ciclesonide, on an allergen-induced asthmatic response in rats and its prolonged anti-inflammatory activity in vitro Source: Eur Respir J 2002; 20: Suppl. 38, 91s Year: 2002
Systemic bioavailability of inhaled corticosteroids: appropriate and comparable methodology Source: Eur Respir J 2001; 18: 246 Year: 2001
Cancer-protective effects of inhaled corticosteroids in COPD are likely related to modification of epithelial activation Source: Eur Respir J, 54 (3) 1901088; 10.1183/13993003.01088-2019 Year: 2019
The effect of inhaled and/or systemic corticosteroids on bone metabolism in asthmatic children Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007
Anti-angiogenic activity of carebastine: a plausible mechanism affecting airway remodelling Source: Eur Respir J 2009; 34: 958-966 Year: 2009
Reversible intracellular esterification increases budesonide airway selectivity Source: Eur Respir J 2001; 18: Suppl. 33, 158s Year: 2001
Effect of switching from high-dose inhaled corticosteroid (ICS) to low-dose ICS plus an inhaled long-acting β2 -agonist on asthma control, airway inflammation and remodeling, and gene expression in airway epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 35s Year: 2003
Repeated inhalation of the new topical steroid ciclesonide does not lead to suppression of endogenous cortisol release in healthy subjects Source: Eur Respir J 2001; 18: Suppl. 33, 95s Year: 2001
Role of CF ion transport defect in airway inflammation and implication for antiinflammatory therapies Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease Year: 2012
Pulmonary absorption rate and bioavailability of drugs in vivo in rats: Analysis of structure-absorption relationships Source: Eur Respir J 2003; 22: Suppl. 45, 6s Year: 2003
Laninamivir’s prolonged intrapulmonary retention: Intrapulmonary pharmacokinetics (PK) and the intracellular disposition to support the long-lasting efficacy after an inhaled administration of its prodrug laninamivir octanoate (LO) Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013
Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness Source: Eur Respir J 2006; 27: 1144-1151 Year: 2006